PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 136 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $173,000 | -62.5% | 5,875 | 0.0% | 0.00% | -66.7% |
| Q4 2015 | $461,000 | +4.1% | 5,875 | 0.0% | 0.01% | +12.5% |
| Q3 2015 | $443,000 | -35.4% | 5,875 | 0.0% | 0.01% | -38.5% |
| Q2 2015 | $686,000 | -50.5% | 5,875 | 0.0% | 0.01% | -45.8% |
| Q1 2015 | $1,387,000 | -31.3% | 5,875 | -45.0% | 0.02% | -29.4% |
| Q4 2014 | $2,020,000 | -21.1% | 10,675 | -0.5% | 0.03% | -24.4% |
| Q3 2014 | $2,560,000 | +68.2% | 10,730 | -53.5% | 0.04% | +73.1% |
| Q2 2014 | $1,522,000 | -36.6% | 23,065 | 0.0% | 0.03% | -38.1% |
| Q1 2014 | $2,402,000 | +11.2% | 23,065 | +10.5% | 0.04% | +10.5% |
| Q4 2013 | $2,160,000 | +44.5% | 20,865 | -25.1% | 0.04% | +31.0% |
| Q3 2013 | $1,495,000 | – | 27,865 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 507,500 | $121,074,000 | 24.90% |
| BB BIOTECH AG | 476,991 | $113,796,000 | 4.63% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $1,356,668,000 | 3.35% |
| WEATHERBIE CAPITAL, LLC | 101,055 | $24,109,000 | 2.26% |
| Avalon Global Asset Management LLC | 16,000 | $3,817,000 | 2.24% |
| Redmile Group, LLC | 51,025 | $12,173,000 | 1.41% |
| Fernwood Investment Management, LLC | 6,700 | $1,598,000 | 1.38% |
| Iguana Healthcare Management, LLC | 10,000 | $2,386,000 | 1.27% |
| LMR Partners LLP | 56,632 | $13,510,000 | 1.08% |
| FRANKLIN STREET ADVISORS INC /NC | 21,990 | $5,246,000 | 1.00% |